Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 17 | 2019 | 353 | 2.050 |
Why?
|
| Tissue Donors | 11 | 2018 | 167 | 1.390 |
Why?
|
| Delayed Graft Function | 4 | 2018 | 33 | 0.790 |
Why?
|
| Graft Survival | 13 | 2019 | 228 | 0.740 |
Why?
|
| Kidney Failure, Chronic | 4 | 2016 | 519 | 0.560 |
Why?
|
| Health Services Accessibility | 2 | 2017 | 231 | 0.520 |
Why?
|
| Living Donors | 2 | 2017 | 55 | 0.470 |
Why?
|
| Tissue and Organ Procurement | 6 | 2018 | 69 | 0.440 |
Why?
|
| Insurance Coverage | 1 | 2013 | 74 | 0.430 |
Why?
|
| Donor Selection | 4 | 2019 | 31 | 0.390 |
Why?
|
| Acetanilides | 1 | 2010 | 6 | 0.390 |
Why?
|
| Ethnic Groups | 1 | 2013 | 440 | 0.380 |
Why?
|
| Tacrolimus | 1 | 2010 | 44 | 0.380 |
Why?
|
| Piperazines | 1 | 2010 | 56 | 0.380 |
Why?
|
| Complement C1q | 1 | 2010 | 4 | 0.370 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 162 | 0.360 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2010 | 36 | 0.360 |
Why?
|
| Molecular Motor Proteins | 1 | 2010 | 58 | 0.350 |
Why?
|
| Myosin Heavy Chains | 1 | 2010 | 86 | 0.350 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 167 | 0.340 |
Why?
|
| Apolipoproteins | 4 | 2016 | 196 | 0.340 |
Why?
|
| Hearing Loss | 1 | 2008 | 19 | 0.330 |
Why?
|
| Diabetic Neuropathies | 1 | 2008 | 23 | 0.330 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2008 | 20 | 0.330 |
Why?
|
| Amines | 1 | 2008 | 22 | 0.330 |
Why?
|
| Lipoproteins, HDL | 4 | 2016 | 247 | 0.330 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 2114 | 0.330 |
Why?
|
| Anticonvulsants | 1 | 2008 | 63 | 0.320 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 74 | 0.320 |
Why?
|
| Pancreas Transplantation | 3 | 2014 | 80 | 0.290 |
Why?
|
| Female | 17 | 2019 | 18241 | 0.270 |
Why?
|
| Graft Rejection | 3 | 2018 | 149 | 0.260 |
Why?
|
| Survival Rate | 6 | 2018 | 795 | 0.250 |
Why?
|
| Middle Aged | 15 | 2019 | 10872 | 0.250 |
Why?
|
| African Americans | 4 | 2017 | 1373 | 0.250 |
Why?
|
| Caveolin 1 | 2 | 2015 | 13 | 0.250 |
Why?
|
| Retrospective Studies | 10 | 2019 | 3122 | 0.250 |
Why?
|
| Humans | 21 | 2019 | 29220 | 0.230 |
Why?
|
| Male | 15 | 2019 | 17876 | 0.220 |
Why?
|
| Adult | 14 | 2019 | 8468 | 0.200 |
Why?
|
| Kidney Diseases | 2 | 2014 | 239 | 0.190 |
Why?
|
| Prognosis | 5 | 2018 | 1363 | 0.190 |
Why?
|
| Cadaver | 6 | 2018 | 143 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 1079 | 0.160 |
Why?
|
| Cold Ischemia | 1 | 2018 | 7 | 0.160 |
Why?
|
| Time Factors | 4 | 2016 | 2003 | 0.160 |
Why?
|
| C-Peptide | 2 | 2014 | 25 | 0.150 |
Why?
|
| United States | 4 | 2017 | 3648 | 0.140 |
Why?
|
| Aged | 7 | 2019 | 9515 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 4 | 2018 | 287 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 271 | 0.120 |
Why?
|
| Haplotypes | 2 | 2015 | 220 | 0.120 |
Why?
|
| Risk Factors | 6 | 2018 | 3550 | 0.120 |
Why?
|
| Incidence | 1 | 2016 | 1123 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2018 | 670 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 3728 | 0.100 |
Why?
|
| Disease Progression | 2 | 2014 | 572 | 0.100 |
Why?
|
| Young Adult | 5 | 2019 | 2413 | 0.100 |
Why?
|
| Kidney Function Tests | 3 | 2018 | 102 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 370 | 0.100 |
Why?
|
| African Continental Ancestry Group | 1 | 2012 | 350 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2012 | 251 | 0.100 |
Why?
|
| Drug Interactions | 1 | 2010 | 80 | 0.100 |
Why?
|
| Perfusion | 2 | 2008 | 64 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2011 | 59 | 0.090 |
Why?
|
| Nephrotic Syndrome | 1 | 2010 | 12 | 0.090 |
Why?
|
| Kidney Tubules | 1 | 2010 | 25 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 836 | 0.090 |
Why?
|
| Kidney Glomerulus | 1 | 2010 | 30 | 0.090 |
Why?
|
| Genotype | 3 | 2017 | 735 | 0.090 |
Why?
|
| Age Factors | 3 | 2019 | 1110 | 0.090 |
Why?
|
| Anuria | 1 | 2008 | 1 | 0.080 |
Why?
|
| Myoclonus | 1 | 2008 | 2 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 641 | 0.080 |
Why?
|
| Phenotype | 3 | 2016 | 629 | 0.080 |
Why?
|
| Extracorporeal Circulation | 1 | 2008 | 11 | 0.080 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2008 | 35 | 0.080 |
Why?
|
| Organ Preservation | 1 | 2007 | 13 | 0.080 |
Why?
|
| Comorbidity | 1 | 2008 | 546 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2016 | 3108 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2008 | 261 | 0.070 |
Why?
|
| Hypertension | 1 | 2011 | 913 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 293 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 710 | 0.060 |
Why?
|
| Creatinine | 2 | 2016 | 174 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 638 | 0.050 |
Why?
|
| Resource Allocation | 1 | 2017 | 10 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 440 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2017 | 90 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 973 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 466 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 203 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 1168 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 31 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 148 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2016 | 114 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 448 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 91 | 0.030 |
Why?
|
| Registries | 1 | 2016 | 280 | 0.030 |
Why?
|
| Patient Selection | 1 | 2014 | 257 | 0.030 |
Why?
|
| Heredity | 1 | 2012 | 12 | 0.030 |
Why?
|
| Child | 1 | 2019 | 2221 | 0.030 |
Why?
|
| Pedigree | 1 | 2012 | 133 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2012 | 225 | 0.030 |
Why?
|
| Albuminuria | 1 | 2012 | 177 | 0.020 |
Why?
|
| Brain Death | 1 | 2011 | 27 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 3265 | 0.020 |
Why?
|
| Immunosuppression | 1 | 2011 | 80 | 0.020 |
Why?
|
| Pancreas | 1 | 2011 | 79 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2015 | 1131 | 0.020 |
Why?
|
| North Carolina | 1 | 2014 | 1425 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 864 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 466 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 486 | 0.020 |
Why?
|
| Death | 1 | 2008 | 41 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2007 | 42 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 1695 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 1313 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2011 | 2027 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1383 | 0.010 |
Why?
|